{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:53:25Z","timestamp":1761630805465,"version":"3.37.3"},"reference-count":17,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sentinel lymph node (SLN) status has been advocated in several recently published articles as the single most valuable prognostic marker for melanoma, and of greater prognostic importance than more established parameters such as Breslow thickness. A careful examination of the evidence for these claims, however, indicates that they are not substantiated by the available data, are somewhat misleading and suggest misinterpretation of the statistical analysis of the papers to which they refer. We will examine the basis for these claims and show why they are invalid.<\/jats:p>","DOI":"10.1111\/ajd.12732","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T12:12:42Z","timestamp":1508847162000},"page":"256-258","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sentinel lymph node biopsy status is not the most powerful predictor of prognosis in cutaneous melanoma"],"prefix":"10.1111","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1021-1859","authenticated-orcid":false,"given":"Samuel","family":"Zagarella","sequence":"first","affiliation":[{"name":"Concord Hospital Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Lee","sequence":"additional","affiliation":[{"name":"School of Pathology and Laboratory Medicine University of Western Australia Crawley Western Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Heenan","sequence":"additional","affiliation":[{"name":"School of Pathology and Laboratory Medicine University of Western Australia Crawley Western Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"e_1_2_3_2_1","first-page":"h5940","article-title":"Sentinel Lymph Node Biopsy for Mellanoma","volume":"351","author":"Menzies A","year":"2015","journal-title":"Br. Med. J."},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.8539"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4799"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310460"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13676"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20084"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.3.976"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.10.825"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f4919"},{"key":"e_1_2_3_11_1","unstructured":"DuerdenM.What are Hazard Ratios.www.whatisseries.co.uk. (Accessed 1st January 2016)."},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1214\/ss\/1177010394"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605849"},{"key":"e_1_2_3_14_1","unstructured":"StiegalE XiongDet\u00a0al.The prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma. Presentation at the 49th American College of Mohs Annual Meeting April 28th 2017."},{"key":"e_1_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613210"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000086543.45557.cb"},{"key":"e_1_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04867.x"},{"key":"e_1_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.2497"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajd.12732","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.12732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T04:43:55Z","timestamp":1734410635000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.12732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1111\/ajd.12732"],"URL":"https:\/\/doi.org\/10.1111\/ajd.12732","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"type":"print","value":"0004-8380"},{"type":"electronic","value":"1440-0960"}],"subject":[],"published":{"date-parts":[[2017,10,24]]},"assertion":[{"value":"2017-08-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-08-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}